Minoxidil water soluble formulation - Tritech Biopharmaceuticals

Drug Profile

Minoxidil water soluble formulation - Tritech Biopharmaceuticals

Latest Information Update: 20 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tritech Biopharmaceuticals
  • Class Antihypertensives; Peripheral vasodilators; Piperidines
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preregistration Alopecia

Most Recent Events

  • 19 Apr 2017 Preregistration for Alopecia in Taiwan (Topical) prior to April 2017 (Tritech Biopharmaceuticals pipeline, April 2017)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top